If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

Share Price is delayed by 15 minutes
Get Live Data
383.20    0.20 (0.05%)
Bid:
382.80
Ask:
383.00
Spread: 0.20 (0.052%)
Market Cap: £7.88b
MKS Live PriceLast checked at - London Stock Exchange

Intraday Marks & Spencer Share Chart

3rd Quarter Trading Statement

9 Jan 2020 07:00

RNS Number : 2174Z
Marks & Spencer Group PLC
09 January 2020
 

 

MARKS AND SPENCER GROUP PLC

QUARTER 3 2019/20 TRADING STATEMENT

13 WEEKS TO 28 DECEMBER 2019

 

'Improved trading performance reflecting progress of transformation strategy' 

 

Third quarter revenue, constant currency

 

£m

Total

Like-for-like

Total UK

 

2,767

-0.6%

0.2%

Food

 

1,704

1.5%

1.4%

Clothing & Home

 

1,063

 -3.7%

-1.7%

International

 

251

-2.3%

 

 

Group

 

3,018

-0.7%

 

 

Highlights

·; Trading reflects ongoing progress of transformation strategy 

·; UK like-for-like revenue slightly up, driven by improved quarter in both main businesses

·; Food business maintains momentum of H1 with positive like-for-like revenue and further improvement in volumes, with standout performance in the 2-week Christmas period as customers responded to sharper value and more relevant innovation

·; Clothing & Home improved run rate from H1 reflecting strong initial customer reception of Autumn ranges with signs of continuing recovery in core Womenswear, offset by underperformance in Menswear and Gifting

·; Decisive actions to drive trade in-season including improved availability, a reduction in options and improving value helped reduce the value of stock into sale by 12%

·; Full year guidance unchanged, although gross margins expected to be around lower end of guidance, largely offset by cost reduction programme

Steve Rowe, Chief Executive, said: "We delivered an improved performance in Q3 across both main businesses. The Food business continued to outperform the market and Clothing and Home had a strong start to the quarter, albeit this was followed by a challenging trading environment in the lead up to Christmas. As we drive a faster pace of change, disappointing one-off issues - notably waste and supply chain in the Food business, the shape of buy in Menswear and performance in our Gifting categories - held us back from delivering a stronger result. However, the changes we made earlier in the year in Clothing have arrested the worst of the issues of the first six months and we are progressively building a much stronger team for the future."

Additional points:

Clothing & Home UK online revenue was up 1.5%, which was lower than expected. Revenue was adversely impacted by competitor discounting in December and lower furniture dispatches at the start of the quarter. We generated an improved run rate in traffic and orders, started to implement improvements to search and personalisation in the period and launched an instalment payment option. 

International revenue continued to reflect investment in price and franchise partner driven stock efficiencies. However, this investment translated into solid volume growth with retail sales of partners up, excluding the effects of disruption in Hong Kong.

We will report full year results on 20 May 2020.

- Ends -

Statements made in this announcement that look forward in time or that express management's beliefs, expectations or estimates regarding future occurrences and prospects are "forward-looking statements" within the meaning of the United States federal securities laws. These forward-looking statements reflect Marks & Spencer's current expectations concerning future events and actual results may differ materially from current expectations or historical results. Any such forward-looking statements are subject to various risks and uncertainties, including failure by Marks & Spencer to predict accurately customer preferences; decline in the demand for products offered by Marks & Spencer; competitive influences; changes in levels of store traffic or consumer spending habits; effectiveness of Marks & Spencer's brand awareness and marketing programmes; general economic conditions or a downturn in the retail or financial services industries; acts of war or terrorism worldwide; work stoppages, slowdowns or strikes; and changes in financial and equity markets. For further information regarding risks to Marks & Spencer's business, please consult the risk management section of the 2019 Annual Report (pages 27-33).

The forward-looking statements contained in this document speak only as of the date of this announcement, and Marks & Spencer does not undertake to update any forward-looking statement to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

 

For further information, please contact:

Investor Relations:

Fraser Ramzan +44 (0)20 3884 7080

Hannah Chambers +44 (0)20 3882 4714

Corporate Press Office: +44 (0)20 8718 1919

 

Investor & Analyst Conference Call:

The call will be hosted by Steve Rowe at 8.30am on Thursday 9 January 2020:

Dial in number: +44 (0)330 336 9125

Confirmation Code: 7835007

A recording of this call will be available until Thursday 16 January 2020:

Telephone: +44 (0) 20 7660 0134

Replay code: 7835007

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUPUPCGUPUGBR
Date   Source Headline
8th Nov 20237:00 amRNSHalf-year Report
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:01 pmRNSDirector/PDMR Shareholding
2nd Oct 20239:00 amRNSTotal Voting Rights
28th Sep 20233:18 pmRNSDirector/PDMR Shareholding
20th Sep 20233:33 pmRNSHolding(s) in Company
20th Sep 20239:00 amRNSDirector/PDMR Shareholding
19th Sep 20239:01 amRNSDirector/PDMR Shareholding
1st Sep 20239:00 amRNSTotal Voting Rights
30th Aug 202310:34 amRNSDirector/PDMR Shareholding
16th Aug 20233:00 pmRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSTrading Update and Outlook for the Year
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 202311:33 amRNSDirector/PDMR Shareholding
7th Jul 20234:18 pmRNSDirector/PDMR Shareholding
4th Jul 20232:13 pmRNSResult of AGM
3rd Jul 20239:00 amRNSTotal Voting Rights
3rd Jul 20239:00 amRNSBlock listing Interim Review
28th Jun 20232:01 pmRNSDirector/PDMR Shareholding
19th Jun 20234:41 pmRNSDirector/PDMR Shareholding
8th Jun 20235:01 pmRNSHolding(s) in Company
7th Jun 20232:56 pmRNSHolding(s) in Company
6th Jun 202310:00 amRNSAnnual Financial Report
1st Jun 202312:19 pmRNSDirector/PDMR Shareholding
1st Jun 20239:00 amRNSTotal Voting Rights
24th May 20237:00 amRNSFinal Results
2nd May 20239:00 amRNSTotal Voting Rights
28th Apr 202310:40 amRNSDirector/PDMR Shareholding
3rd Apr 20239:00 amRNSTotal Voting Rights
28th Mar 20232:04 pmRNSDirector/PDMR Shareholding
20th Mar 20233:53 pmRNSHolding(s) in Company
1st Mar 20239:00 amRNSTotal Voting Rights
28th Feb 202310:23 amRNSDirector/PDMR Shareholding
24th Feb 20239:00 amRNSDirectorate Change
1st Feb 20239:00 amRNSTotal Voting Rights
30th Jan 202310:18 amRNSDirector/PDMR Shareholding
16th Jan 20231:35 pmRNSHolding(s) in Company
16th Jan 202310:30 amRNSChange to Board Committee Membership
13th Jan 20234:16 pmRNSHolding(s) in Company
12th Jan 20237:00 amRNSChristmas 2022/2023 Trading
5th Jan 20234:02 pmRNSHolding(s) in Company
3rd Jan 20239:00 amRNSTotal Voting Rights
3rd Jan 20239:00 amRNSBlock listing Interim Review
29th Dec 202210:40 amRNSDirector/PDMR Shareholding
13th Dec 202210:37 amRNSDirector Declaration
12th Dec 20221:45 pmRNSDirectorate Change
9th Dec 20223:27 pmRNSDirector/PDMR Shareholding
1st Dec 20229:00 amRNSTotal Voting Rights
29th Nov 20221:36 pmRNSDirector/PDMR Shareholding
18th Nov 202210:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.